On Tuesday 19 November, a panel from our London life sciences team presented a webinar on what you need to know when using AI tools in drug development, in order to best protect your invention from an IP perspective, and avoid falling foul of EU and UK data protection laws.
Please log-in or register to access Engage and set your preferences
Create a free account for access to this publication and our vast catalogue of legal updates
Log-in to continue reading
Scan this QR Code to share this content
